Table I.
FAS |
PP |
||||
---|---|---|---|---|---|
MSS by visit | BNO 1016 480 mg (n = 294) | Placebo (n = 295) | BNO 1016 480 mg (n = 213) | Placebo (n = 220) | |
Visit 1 (day 0) | Mean (SD) | 10.02 (1.61) | 9.87 (1.52) | 9.70 (1.28) | 9.65 (1.27) |
Visit 2 (day 3) | Mean (SD) | 7.71 (2.40) | 7.86 (2.71) | 7.50 (2.11) | 7.78 (2.53) |
Visit 3 (day 7) | Mean (SD) | 5.54 (2.74) | 6.15 (3.13) | 5.15 (2.45) | 6.14 (3.06) |
Visit 4 (day 10) | Mean (SD) | 4.11 (2.66) | 5.05 (3.44) | 3.77 (2.32) | 4.93 (3.42) |
Visit 5 (day 14)*† | Mean (SD) | 2.47 (2.55) | 3.63 (3.63) | 2.06 (2.31) | 3.76 (3.76) |
p value*† | p < 0.0001 | p < 0.0001 | |||
Difference [placebo – BNO 1016 480 mg] (SD) | 1.17 (3.14) | 1.70 (3.13) |
*One-sided; alpha = 0.025.
†ANCOVA.
FAS, full analysis set; PP, per-protocol population; SD, standard deviation.